Skip to main content
Recent Patents on Cardiovascular Drug Discovery publishes review articles on recent patents in the field of cardiovascular drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on cardiovascular drug discovery is also included in the journal. The journal is essential reading for all researchers involved in cardiovascular drug design and discovery.

Publisher: Bentham Science Publishers

Volume 6, Number 1, 2011

Articles

Novel Agents for the Acute Conversion of Atrial Fibrillation: Focus on Vernakalant
pp. 1-8(8)
Authors: Cialdella, Pio; Pedicino, Daniela; Santangeli, Pasquale

Favourites:
ADD

Levosimendan: From Basic Science to Clinical Trials
pp. 9-15(7)
Authors: Rognoni, Andrea; Lupi, Alessandro; Lazzero, Maurizio; S. Bongo, Angelo; Rognoni, Giorgio

Favourites:
ADD

Sobetirome: A Selective Thyromimetic for the Treatment of Dyslipidemia
pp. 16-19(4)
Authors: Tancevski, Ivan; Demetz, Egon; Eller, Philipp

Favourites:
ADD

The Protective Effects of Levosimendan on Ischemia/Reperfusion Injury and Apoptosis
pp. 20-26(7)
Authors: Scheiermann, Patrick; Beiras-Fernandez, Andres; Mutlak, Haitham; Weis, Florian

Favourites:
ADD

Ultrasound Microbubble Contrast and Current Clinical Applications
pp. 27-41(15)
Authors: Dindyal, Shiva; Kyriakides, Constantinos

Favourites:
ADD

Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
pp. 42-54(13)
Authors: A. Rodriguez-Granillo, Gaston; Rodriguez-Granillo, Agustina; Milei, Jose

Favourites:
ADD

Latest Therapeutic Novelties and Patents in Pulmonary Hypertension
pp. 55-60(6)
Authors: F. Hardavella, Georgia; S. Dionellis, Georgios; G. Kantza, Christina; G. Koulouris, Nikolaos; Alchanatis, Manos

Favourites:
ADD
Favourites:
ADD

Patent Selections:
pp. 70-73(4)
Author: Bentham Science Publishers

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content